Literature DB >> 31820978

Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective.

Han Zhang1,2, Qi-Dong You1,2, Xiao-Li Xu1,2.   

Abstract

Stimulator of interferon genes (STING) is an adaptor protein that induces the secretion of type I interferons and proinflammatory cytokines and is triggered by cytosolic DNA of pathogen and host origins. Given that STING is a mediator in the immune system, pharmacological modulation of STING has shown viable therapeutic effects for pathogen infection, cancer, and inflammatory diseases. In the past decade, the substantial development in this field has encouraged the discovery of STING modulators. Here, we will summarize the current understanding of STING structure, survey the status quo of STING modulators, compare established bioassay methods, review the chemical structures and bioactivities of agonists and inhibitors, and propose suggestions and insights for the future exploitation of STING modulators.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31820978     DOI: 10.1021/acs.jmedchem.9b01039

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Potential Cancer Treatment by Agonists of the Stimulator of Interferon Genes.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2020-04-13       Impact factor: 4.345

Review 2.  Post-Translational Modifications of STING: A Potential Therapeutic Target.

Authors:  Jiaqi Kang; Jie Wu; Qinjie Liu; Xiuwen Wu; Yun Zhao; Jianan Ren
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  Targeting Stimulator of Interferon Genes (STING) for the Potential Treatment of Cancer and Infectious Diseases.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2021-02-23       Impact factor: 4.345

4.  Catalytic asymmetric and stereodivergent oligonucleotide synthesis.

Authors:  Aaron L Featherston; Yongseok Kwon; Matthew M Pompeo; Oliver D Engl; David K Leahy; Scott J Miller
Journal:  Science       Date:  2021-02-12       Impact factor: 47.728

5.  Stimulator of IFN genes mediates neuroinflammatory injury by suppressing AMPK signal in experimental subarachnoid hemorrhage.

Authors:  Yucong Peng; Jianfeng Zhuang; Guangyu Ying; Hanhai Zeng; Hang Zhou; Yang Cao; Huaijun Chen; Chaoran Xu; Xiongjie Fu; Hangzhe Xu; Jianru Li; Shenglong Cao; Jingyin Chen; Chi Gu; Feng Yan; Gao Chen
Journal:  J Neuroinflammation       Date:  2020-05-25       Impact factor: 8.322

Review 6.  Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment.

Authors:  Jin Li; Diane J Burgess
Journal:  Acta Pharm Sin B       Date:  2020-05-31       Impact factor: 11.413

Review 7.  The Complexity of the cGAS-STING Pathway in CNS Pathologies.

Authors:  Amelia L Fryer; Amar Abdullah; Juliet M Taylor; Peter J Crack
Journal:  Front Neurosci       Date:  2021-02-09       Impact factor: 4.677

8.  Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus.

Authors:  Li Xiaohong; Zhang Zhenting; Yu Yunjie; Cai Wei; Xu Xiangjin; Xie Kun; Lin Xin; Lin Lu; Lu Jun; Chen Pin
Journal:  J Cell Mol Med       Date:  2022-02-17       Impact factor: 5.310

Review 9.  Nanodelivery of STING agonists against cancer and infectious diseases.

Authors:  Jiarong Zhou; Christian J Ventura; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Aspects Med       Date:  2021-08-02

Review 10.  Bacterial Cyclic Dinucleotides and the cGAS-cGAMP-STING Pathway: A Role in Periodontitis?

Authors:  Samira Elmanfi; Mustafa Yilmaz; Wilson W S Ong; Kofi S Yeboah; Herman O Sintim; Mervi Gürsoy; Eija Könönen; Ulvi K Gürsoy
Journal:  Pathogens       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.